Fusarium infections of the skin

Current Opinion in Infectious Diseases

Volumn 20, Issue 2, 2007, Pages 115-117

  Hay, Rod J ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ITRACONAZOLE; POSACONAZOLE; TERBINAFINE; VORICONAZOLE;

CLINICAL EXAMINATION; EDITORIAL; ENDOPHTHALMITIS; FUSARIUM; HUMAN; KERATITIS; KERATOMYCOSIS; MYCOSIS; NAIL; NEUTROPENIA; NONHUMAN; ONYCHOMYCOSIS; PARONYCHIA; SKIN INFECTION; TINEA PEDIS;

ANTIFUNGAL AGENTS; DERMATOMYCOSES; FUSARIUM; HUMANS; ITRACONAZOLE; PYRIMIDINES; TRIAZOLES;

EID: 33847375550     PISSN: 09517375     EISSN: None     Source Type: Journal    
DOI: 10.1097/QCO.0b013e328014392d     Document Type: Editorial

References (25)

1. Moore CB, Denning DW. Deep hyalohyphomycosis. In: Merz WG, Hay RJ, editors. Medical mycology. Topley and Wilson's microbiology and microbial infections, 10th edition. London: Hodder Arnold; 2005. pp. 739-762.
2. Raad I, Tarrand J, Hanna H, et al. Epidemiology, molecular mycology, and environmental sources of Fusarium infection in patients with cancer. Infect Cont Hosp Epidemiol 2002; 23:532-537.
3. Nir-Paz R, Strahilevitz J, Shapiro M, et al. Clinical and epidemiological aspects of infections caused by Fusarium species: a collaborative study from Israel. J Clin Microbiol 2004; 42:3456-3461.
4. Girmenia C, Pagano L, Corvatta L, et al. The epidemiology of fusariosis in patients with haematological diseases. Gimema Infection Programme. Br J Haematol 2000; 111:272-276.
5. Hennequin C, Lavarde V, Poirot JL, et al. Invasive Fusarium infections: a retrospective survey of 31 cases. The French 'Groupe d'Etudes des Mycoses Opportunistes' GEMO. J Med Vet Mycol 1997; 35:107-114.
6. Boutati EI, Anaissie EJ. Fusarium, a significant emerging pathogen in patients with hematologic malignancy: ten years' experience at a cancer center and implications for management. Blood 1997; 90:999-1008.
7. Piraccini BM, Tosti A. White superficial onychomycosis: epidemiological, clinical, and pathological study of 79 patients. Arch Dermatol 2004; 140:696-701.
8. Calado NB, Sousa F Jr, Gomes NO, et al. Fusarium nail and skin infection: a report of eight cases from Natal. Brazil Mycopathol 2006; 161:27-31.
9. Romano C, Miracco C, Difonzo EM. Skin and nail infections due to Fusarium oxysporum in Tuscany, Italy. Mycoses 1998; 41:433-437.
10. Lee HJ, Koh BK, Moon JS, et al. A case of melanonychia caused by Fusarium solani. Br J Dermatol 2002; 147:607-608.
11. Gianni C, Cerri A, Crosti C. Unusual clinical features of fingernail infection by Fusarium oxysporum. Mycoses 1997; 40:455-459.
12. Romano C, Gianni C. Tinea pedis resulting from Fusarium spp. Int J Dermatol 2002; 41:360-362.
13. Pereiro M Jr, Labandeira J, Toribio J. Plantar hyperkeratosis due to Fusarium verticillioides in a patient with malignancy. Clin Exp Dermatol 1999; 24:175-178.
14. Girardi M, Glusac EJ, Imaeda S. Subcutaneous Fusarium foot abscess in a renal transplant patient. Cutis 1999; 63:267-270.
15. Willemsen MJ, De Coninck AL, Coremans-Pelseneer JE, et al. Parasitic invasion of Fusarium oxysporum in an arterial ulcer in an otherwise healthy patient. Mykosen 1986; 29:248-252.
16. Latenser BA. Fusarium infections in burn patients: a case report and review of the literature. J Burn Care Rehabil 2003; 24:285-288.
17. Di Pietro A, Huertas-Gonzalez MD, Gutierrez-Corona JF, et al. Molecular characterization of a subtilase from the vascular wilt fungus Fusarium oxysporum. Mol Plant-Microbe Interact 2001; 14:653-662.
18. Oycka CA, Gugnani HC. Keratin degradation by Scytalidium species and Fusarium solani. Mycoses 1998; 41:73-76.
19. Bhavanishankar TN, Ramesh HP, Shantha T. Dermal toxicity of Fusarium toxins in combinations. Arch Toxicol 1988; 61:241-244.
20. Hymery N, Sibiril Y, Parent-Massin D. In vitro effects of trichothecenes on human dendritic cells. Toxicol In Vitro 2006; 20:899-909.
21. Naiker S, Odhav B. Mycotic keratitis: profile of Fusarium species and their mycotoxins. Mycoses 2004; 47:50-56.
22. Alexandrakis G, Jalali S, Gloor P. Diagnosis of Fusarium keratitis in an animal model using the polymerase chain reaction. Br J Ophthalmol 1998; 82:306-311.
23. Raad II, Hachem RY, Herbrecht R, et al. Posaconazole as salvage treatment for invasive fusariosis in patients with underlying hematologic malignancy and other conditions. Clin Infect Dis 2006; 42:1398-1403.
24. Sponsel WE, Graybill JR, Nevarez HL, Dang D. Ocular and systemic posaconazole (SCH-56592) treatment of invasive Fusarium solani keratitis and endophthalmitis. Br J Ophthalmol 2002; 86:829-830.
25. Klont RR, Eggink CA, Rijs AJ, et al. Successful treatment of Fusarium keratitis with cornea transplantation and topical and systemic voriconazole. Clin Infect Dis 2005; 40:e110-e112.